Camance, Aidelyn C.
HRN: 29-27-56 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2026
CEFTRIAXONE 1G (VIAL)
07/07/2026
07/13/2026
IV
2g
OD
CAP-MR
Checking Initial Appropriateness
07/07/2026
AZITHROMYCIN 500MG TABLET (TAB)
07/07/2026
07/11/2026
PO
500mg
OD
CAP-MR
Checking Initial Appropriateness
07/09/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/09/2026
07/16/2026
IV
2.25g
Q8
Cap Hr
Checking Initial Appropriateness
07/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/12/2026
07/19/2026
IV
2.25g
Q6
Cap Hr
Checking Final Appropriateness
07/12/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
07/12/2026
07/12/2026
IV
750mg
Now As LD
CAP HR
Checking Final Appropriateness
07/12/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
07/12/2026
07/19/2026
IV
500mg
Q48
Cap Hr
Checking Final Appropriateness